Potential antiparkinsonism agents. Quinuclidinyl benzhydryl ethers.
D000109:Acetylcholine / Q000037:antagonists & inhibitors; D000818:Animals; D001285:Atropine / Q000494:pharmacology; D004155:Diphenhydramine / Q000494:pharmacology; D004987:Ethers / Q000138:chemical synthesis / Q000494:pharmacology; D006168:Guinea Pigs; D006634:Histamine H1 Antagonists; D007082:Ileum / Q000187:drug effects; D066298:In Vitro Techniques; D051379:Mice; D010276:Parasympatholytics / Q000138:chemical synthesis / Q000494:pharmacology; D011680:Pupil / Q000187:drug effects; D011812:Quinuclidines / Q000138:chemical synthesis / Q000494:pharmacology; D014203:Tremorine / Q000037:antagonists & inhibitors
D004987:Ethers; D006634:Histamine H1 Antagonists; D010276:Parasympatholytics; D011812:Quinuclidines; D001285:Atropine; D004155:Diphenhydramine; D000109:Acetylcholine; D014203:Tremorine